Biotech Company That Botched Vaccines Faces Investor Revolt

By July 6, 2021 No Comments

In the latest shareholder lawsuit, a pension fund accused executives at Emergent BioSolutions of insider trading. The company, under investigation by Congress, has halted manufacturing of Covid-19 vaccines at its Baltimore factory at regulators’ request.

Leave a Reply